Deepnoid

Deepnoid develops and commercializes artificial intelligence solutions focused on medical imaging diagnostics—especially brain MRI/MRA, chest X-rays, low-dose CT scans—and workflow automation. Its flagship cloud-based LLM solution M4CXR outperforms general-purpose models like ChatGPT in interpreting chest radiographs. The company’s platforms are used clinically to assist radiologists and clinicians with disease screening/detection—including lung diseases/cancer and brain aneurysms—and have been validated through peer-reviewed publications. In partnership with GeneCast, Deepnoid is developing a next-generation multimodal diagnostic integrating liquid biopsy ctDNA analysis with its proprietary imaging-AI to enable earlier/more accurate cancer detection starting with lung cancer. The company has also expanded into security screening automation using similar core technologies.